Christi Shaw an Eli Lilly executive has been named the new head of Kite Pharma which is focused on treatments that genetically engineer patients white blood cells to attack cancer. httpsbuff.ly2XXCmdGÂ

Christi Shaw, an Eli Lilly executive, has been named the new head of Kite Pharma, which is focused on treatments that genetically engineer patients’ white blood cells to attack cancer. https://buff.ly/2XXCmdG 

21:00 EDT 11 Jul 2019 | STAT

Christi Shaw, an Eli Lilly executive, has been named the new head of Kite Pharma, which is focused on treatments that genetically engineer patients’ white blood cells to attack cancer. https://buff.ly/2XXCmdG 

More From BioPortfolio on "Christi Shaw, an Eli Lilly executive, has been named the new head of Kite Pharma, which is focused on treatments that genetically engineer patients’ white blood cells to attack cancer. https://buff.ly/2XXCmdG "